Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/MST CONTINUS

Approved

STANDARD

MST CONTINUS

Bard Pharmaceuticals Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: a7ca27ebbab383ef
Company: Bard Pharmaceuticals Limited
Type: Standard

Approval Details

Approval Id: a7ca27ebbab383ef
Drug Approval Philippines Name: MST CONTINUS
Product Name: MST CONTINUS
Registration Number: DR-XY13019
Brand Name: MST CONTINUS
Generic Name: Morphine Sulfate
Dosage Form: Modified-Release Tablet
Dosage Strength: 30 mg
Manufacturer: Bard Pharmaceuticals Limited
Importer: Mundipharma Distribution GmbH (Philippine Branch)
Company Detail Path: /organization/bard-pharmaceuticals-limited
Issuance Date: 25 September 2020
Expiry Date: 17 July 2025
Pharmacologic Category: Opioid Analgesic (natural Opium Alkaloid
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a7ca27ebbab383ef

Type

Standard

Back to Philippines FDA Approvals

MST CONTINUS - Philippines FDA Drug Approval Details